Pharmigene, Inc. (TPEX:7595)
Taiwan · Delayed Price · Currency is TWD 10.90
-0.85 (-7.23%)
Oct 17, 2025, 12:44 PM CST
Pharmigene Market Cap
Pharmigene has a market cap or net worth of 565.21 million as of October 17, 2025. Its market cap has decreased by -41.67% in one year.
Market Cap
565.21M
Enterprise Value
1.11B
Revenue
149.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.90
Market Cap Chart
Since December 22, 2020, Pharmigene's market cap has decreased from 1.08B to 565.21M, a decrease of -47.78%. That is a compound annual growth rate of -12.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 565.21M | -21.40% |
| Dec 31, 2024 | 719.13M | -31.16% |
| Dec 29, 2023 | 1.04B | 21.08% |
| Dec 30, 2022 | 862.78M | -8.53% |
| Dec 30, 2021 | 943.19M | -13.20% |
| Dec 31, 2020 | 1.09B | 0.40% |
| Dec 22, 2020 | 1.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 251.26B |
| PharmaEssentia | 190.83B |
| Bora Pharmaceuticals Co., LTD. | 80.18B |
| Lotus Pharmaceutical | 78.76B |
| Lumosa Therapeutics | 48.85B |
| Oneness Biotech | 30.37B |
| Polaris Group | 27.74B |
| Center Laboratories | 25.27B |